EGFR and lung cancer: In a recent study, Yu et al. demonstrated that m5C modification increases the stability of YAP1 mRNA and promotes the secretion of exosomes in lung cancer cells, which may be associated with their resistance to the treatment of third-generation EGFR-TKI [18].